Oak Creek, WI, United States of America

Jamie R Giesler

This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jamie R Giesler. Retrieved from https://idiyas.com/inventor/jamie-r-giesler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jamie R Giesler: Innovator in Matrix Metalloproteinase Inhibition

Introduction

Jamie R Giesler is a notable inventor based in Oak Creek, Wisconsin. She has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for matrix metalloproteinases. Her work is crucial for advancing treatments for diseases where these enzymes play a pivotal role.

Latest Patents

Jamie R Giesler holds a patent for C-terminal ketone inhibitors of matrix metalloproteinases and TNF.alpha. This patent describes C-terminal compounds that are potent inhibitors of matrix metalloproteinases. These compounds are useful in treating diseases associated with matrix metalloproteinase activity. The patent also discloses compositions that inhibit matrix metalloproteinases and methods for applying these inhibitors in mammals.

Career Highlights

Giesler is currently employed at Abbott Laboratories Corporation, a leading global healthcare company. Her role involves research and development focused on innovative therapeutic solutions. With one patent to her name, she has established herself as a key contributor in her field.

Collaborations

Throughout her career, Jamie has collaborated with esteemed colleagues such as Steven K Davidsen and Alan S Florjancic. These partnerships have enhanced her research efforts and contributed to the advancement of their shared goals in biochemistry and pharmacology.

Conclusion

Jamie R Giesler exemplifies

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…